This inventor holds 2 USPTO granted patents. Top assignees: Sanofi Sa, Sterling Winthrop Inc.. Active years: 1996-1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-1997
Title: The Innovative Contributions of Jeffrey Johnson
Introduction
Jeffrey Johnson is a notable inventor based in Phoenixville, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that target matrix metalloproteinases. With a total of 2 patents, his work has the potential to impact the treatment of various diseases.
Latest Patents
Johnson's latest patents focus on hydroxamic acid and carboxylic acid derivatives. These patents disclose a novel class of hydroxamic and carboxylic acid-based matrix metalloproteinase inhibitor derivatives. The disclosures further relate to pharmaceutical compositions containing such compounds and their use in treating matrix metalloproteinase-induced diseases. This innovative approach highlights the importance of his research in the pharmaceutical industry.
Career Highlights
Throughout his career, Jeffrey Johnson has worked with prominent companies such as Sterling Winthrop Inc. and Sanofi S.A. His experience in these organizations has allowed him to develop and refine his expertise in pharmaceutical innovations.
Collaborations
Some of his notable coworkers include Madhusudhan R Gowravaram and Ewell R Cook. Their collaboration has likely contributed to the advancements in the projects they have worked on together.
Conclusion
Jeffrey Johnson's contributions to the field of pharmaceuticals through his innovative patents and collaborations demonstrate his commitment to advancing medical science. His work continues to pave the way for new treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile